Latest Breast cancer treatment Stories
A Follow-On Combination Trial in First-Line Ovarian Cancer in the Neo-Adjuvant Setting Has Been Accepted by FDA LAWRENCEVILLE, N.J., Feb.
SAN FRANCISCO, Feb. 17, 2015 /PRNewswire/ -- Women's wellness provider Ella Health has appointed industry leader Dawn-Marie Ickes as director of physical therapy and integrative wellness.
WORCESTER, Mass. and TORONTO, Feb.
LUGANO, Switzerland and COPENHAGEN, Denmark, February 5, 2015 /PRNewswire/ -- - Elsiglutide is a GLP-2 receptor agonist with potential as a first-ever therapy to help cancer
Advanced Radiation Therapy System Ideally Suited for Efficient, Effective Treatment of Range of Breast Cancer Cases SUNNYVALE, Calif., Feb.
A new study published in The Oncologist details a novel approach to identifying patients with stage II colorectal cancer who are most likely to benefit from additional treatment due to a high
Hospital Recognized as Only Illinois Facility to Receive Award for Providing Quality Care CHICAGO, Feb.
LAWRENCEVILLE, N.J., Jan.
Lead Immunotherapy Product Candidate GEN-1 to Enter Dose Escalating Clinical Study in the Second Half of 2015 LAWRENCEVILLE, N.J., Jan.
MarginProbe® Improves Surgeons' Ability to Identify in the Operating Room "Cancers on the Margins" - Reducing Risk of Additional Surgical Intervention Following Lumpectomy NEW YORK,
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.